24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
62.64% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
37.36% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
53.54% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
34.58% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
7.08% |
|
MEMBRANE TRANSPORT |
3.96% |
|
CANCER |
.83% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
60.27% |
|
INFLUENZA |
9.88% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
8.31% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
3.86% |
|
RCA OLIGOMER STABILITY SIMULATIONS |
3.75% |
|
CANCER |
3.51% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
2.27% |
|
RCA OLIGOMERIC STABILITY MD SIMULATIONS |
2.03% |
|
RCA STABILITY SIMULATIONS |
1.86% |
|
RCA OLIGOMERIC STABILITY TEMPERATURE SIMULATION |
.95% |
|
MEMBRANE TRANSPORT |
.87% |
|
RCA OLIGOMERIC STABILITY HEAT STRESS SIMULATIONS |
.84% |
|
RCA OLIGOMER STABILITY MD SIMULATIONS HEAT STRESS |
.84% |
|
RCA OLIGOMER STABILITY MD SIMULATIONS |
.48% |
|
PARKINSONS |
.22% |
|
RCA OLIGOMERIC STABILITY SIMULATIONS |
.06% |